Related Experiment Videos
Intracranial metrizamide following myelography.
Journal of the Canadian Association of Radiologists
|September 1, 1984
Summary
Cranial CT scans after metrizamide myelography revealed contrast agent migration into the brain. This phenomenon, termed "pseudohydrocephalus," was observed in patients, though direct links to neurological issues remain unclear.
Area of Science:
- Neuroradiology
- Neuroimaging
- Medical Imaging
Background:
- Metrizamide (Amipaque) is a nonionic, water-soluble contrast medium used in myelography.
- Intracranial effects of metrizamide require further investigation.